Jingwei Sun
![Jingwei Sun Jingwei Sun](https://til-therapies.com/wp-content/uploads/sites/262/2024/05/Jingwei-Sun-Speaker-150x150.png)
Company: GRIT Biotechnology New!
Job title: Senior Director of Early Discovery
Seminars:
The Discovery & Development of Next-Generation Long-Lasting Anti-Exhaustion TIL Therapies 2:00 pm
Design and development of function and persistence enhanced GT2 series TIL products engineered by StaViral® virus platform Development of GT3 series TIL products by CRISPR KO of potent immunoregulatory targets identified through ImmuT Finder®, a genome-wide CRISPR/Cas9 screening platform Preliminary safety and efficacy of next-gen TIL products in human trial as monotherapy in advanced solid tumorsRead more
day: Conference Day Two - Track A - PM